Prognostic Significance of Alterations in IDH Enzyme Isoforms in Patients With AML Treated With High Dose Cytarabine and Idarubicin

BACKGROUND: IDH1 and IDH2 gene mutations are novel, recurring molecular aberrations among patients with normal karyotype acute myeloid leukemia (AML). METHODS: Among 358 patients with AML treated on 4 protocols using high dose ara-C plus idarubicin induction, pre-treatment samples were available for...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ravandi, Farhad, Patel, Keyur, Luthra, Rajyalakshmi, Faderl, Stefan, Konopleva, Marina, Kadia, Tapan, Brandt, Mark, Pierce, Sherry, Kornblau, Steven, Andreeff, Michael, Wang, Xuemei, Garcia-Manero, Guillermo, Cortes, Jorge, Kantarjian, Hagop
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4060157/
https://ncbi.nlm.nih.gov/pubmed/22020636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26580
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы